| Title | Claps | Level | Year | L/Y |
|---|---|---|---|---|
|
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia
19 auth. S. Lipshultz, S. Lipsitz, J. Kutok, T. Miller, S. Colan, D. Neuberg, Kristen Stevenson, M. D. Fleming, S. Sallan, V. Franco, ...
Doxorubicin is associated with progressive cardiac dysfunction, possibly through the formation of doxorubicin‐iron complexes leading to free‐radical injury. The authors determined the frequency of hemochromatosis (HFE) gene mutations associated with…
Doxorubicin is associated with progressive cardiac dysfunction, possibly through the formation of doxorubicin‐iron complexes leading to free‐radical injury. The authors determined the frequency of hemochromatosis (HFE) gene mutations associated with hereditary hemochromatosis and their relationship with doxorubicin‐associated cardiotoxicity in survivors of childhood high‐risk acute lymphoblastic leukemia.
Published in
Cancer
|
13
|
7 | 2013 |
Social Media Posts